Nullius in Verba

Nectome, a company founded by Aurelia, has achieved a major breakthrough in brain preservation technology with independent verification from two prominent organizations. Their new method for whole-body, whole-brain human end-of-life preservation can maintain every synapse and cell with enough detail that current neuroscience suggests long-term memories are preserved. The protocol works at room temperature for traditional funerals and remains stable for hundreds of years when cooled. This represents the culmination of nearly a decade of development across two phases: first achieving idealized laboratory preservation (2015-2018), then adapting the technique to real-world human preservation constraints (2018-2025).

The Brain Preservation Foundation awarded Nectome both small- and large-mammal prizes after Ken Hayworth personally supervised and verified preservation of rabbit and pig brains using electron microscopy. The Survival and Flourishing Fund later invested after Andrew Critch witnessed a rat preservation demonstration mimicking human conditions, with samples analyzed by UC Berkeley and University of Chicago researchers. Nectome's aldehyde-stabilized cryopreservation technique has been published in Cryobiology, and their real-world protocol has been submitted as a preprint titled 'Ultrastructural preservation of a whole large mammal brain with a protocol compatible with human physician-assisted death.' Both foundations have reviewed and endorsed the company's claims about their preservation quality.